Works matching IS 15228517 AND DT 2019 AND VI 21 AND IP 10
Results: 17
Genetic variants and cognitive functions in patients with brain tumors.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 10, p. 1297, doi. 10.1093/neuonc/noz094
- By:
- Publication type:
- Article
Genetic and genomic alterations differentially dictate low-grade glioma growth through cancer stem cell–specific chemokine recruitment of T cells and microglia.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 10, p. 1250, doi. 10.1093/neuonc/noz080
- Publication type:
- Article
Forthcoming Meetings.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 10, p. 1339, doi. 10.1093/neuonc/noz148
- Publication type:
- Article
Highlights from the Literature.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 10, p. 1223, doi. 10.1093/neuonc/noz149
- By:
- Publication type:
- Article
EGFR amplification status for clinical trial inclusion: where do we draw the line?
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 10, p. 1215, doi. 10.1093/neuonc/noz146
- By:
- Publication type:
- Article
Differential trajectories of neurocognitive functioning in females versus males following treatment for pediatric brain tumors.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 10, p. 1310, doi. 10.1093/neuonc/noz092
- By:
- Publication type:
- Article
Defining EGFR amplification status for clinical trial inclusion.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 10, p. 1263, doi. 10.1093/neuonc/noz096
- By:
- Publication type:
- Article
CircFOXO3 promotes glioblastoma progression by acting as a competing endogenous RNA for NFAT5.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 10, p. 1284, doi. 10.1093/neuonc/noz128
- By:
- Publication type:
- Article
Hypometabolic gliomas on FET-PET—is there an inverted U-curve for survival?
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 10, p. 1221, doi. 10.1093/neuonc/noz122
- By:
- Publication type:
- Article
Driver mutations in USP8 wild-type Cushing's disease.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 10, p. 1273, doi. 10.1093/neuonc/noz109
- By:
- Publication type:
- Article
To each, his/her own.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 10, p. 1217, doi. 10.1093/neuonc/noz143
- By:
- Publication type:
- Article
Integrating ependymoma molecular subgroups into clinical trials.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 10, p. 1219, doi. 10.1093/neuonc/noz132
- By:
- Publication type:
- Article
Inflaming glioma growth.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 10, p. 1213, doi. 10.1093/neuonc/noz125
- By:
- Publication type:
- Article
Immunotherapy for pediatric brain tumors: past and present.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 10, p. 1226, doi. 10.1093/neuonc/noz077
- By:
- Publication type:
- Article
Photopenic defects on O-(2-[<sup>18</sup>F]-fluoroethyl)-L-tyrosine PET: clinical relevance in glioma patients.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 10, p. 1331, doi. 10.1093/neuonc/noz083
- By:
- Publication type:
- Article
Molecular grouping and outcomes of young children with newly diagnosed ependymoma treated on the multi-institutional SJYC07 trial.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 10, p. 1319, doi. 10.1093/neuonc/noz069
- By:
- Publication type:
- Article
To randomize, or not to randomize, that is the question: using data from prior clinical trials to guide future designs.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 10, p. 1239, doi. 10.1093/neuonc/noz097
- By:
- Publication type:
- Article